Vacuum-Assisted Abdominal Closure Is Safe and Effective:A Cohort Study in 74 Consecutive Patients by Jensen, R O et al.
Syddansk Universitet
Vacuum-Assisted Abdominal Closure Is Safe and Effective
A Cohort Study in 74 Consecutive Patients
Jensen, Rie Overgaard; Buchbjerg, Thomas; Simonsen, R M; Eckardt, Rozy; Qvist, Niels
Published in:
Surgery Research and Practice
DOI:
10.1155/2017/7845963
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license
CC BY
Citation for pulished version (APA):
Jensen, R. O., Buchbjerg, T., Simonsen, R. M., Eckardt, R., & Qvist, N. (2017). Vacuum-Assisted Abdominal
Closure Is Safe and Effective: A Cohort Study in 74 Consecutive Patients. Surgery Research and Practice,
2017, [7845963]. DOI: 10.1155/2017/7845963
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 08. Jan. 2018
Research Article
Vacuum-Assisted Abdominal Closure Is Safe and Effective:
A Cohort Study in 74 Consecutive Patients
R. O. Jensen, T. Buchbjerg, R. M. Simonsen, R. Eckardt, and N. Qvist
Department of Surgery, OUH, Sdr. Boulevard 29, 5000 Odense C, Denmark
Correspondence should be addressed to R. O. Jensen; rijen08@gmail.com
Received 1 June 2017; Accepted 10 August 2017; Published 11 September 2017
Academic Editor: Ahmed H. Al-Salem
Copyright © 2017 R. O. Jensen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. Vacuum-assisted closure (VAC) has, in many instances, become the treatment of choice in patients with abdominal
catastrophes. This study describes the use and outcome of ABThera KCI VAC in the Region Southern Denmark covering a
population of approximately 1.202 mill inhabitants. Method. A prospective multicenter study including all patients treated with
VAC during an eleven-month period. Results. A total of 74 consecutive patients were included. Median age was 64.4 (9–89) years,
64%weremen, andmedian bodymass index was 25 (17–42). Duration of VAC treatment wasmedian 4.5 (0–39) days withmedian 1
(0–16) dressing changes. Seventy per cent of the patients attended the intensive care unit.The 90-daymortalitywas 15%.A secondary
closure of the fasciawas obtained in 84%of the surviving patients. Only one patient developed an enteroatmospheric fistula. Patients
with secondary closure were less likely to develop large hernias and had better self-evaluated physical health score (p < 0,05). No
difference in mental health was found. Conclusion. The abdominal VAC treatment in patients with abdominal catastrophes is safe
and with a relative low complication rate. Whether it might be superior to conventional treatment with primary closure when
possible has yet to be proven in a randomized study.
1. Introduction
Leaving the abdomen open after emergency laparotomy has
gained increased popularity during recent decades. Common
indications are surgery for abdominal hemorrhage (trau-
matic/nontraumatic), peritonitis (generalized or local), acute
pancreatitis, abdominal compartment syndrome (ACS), fas-
cia dehiscence, and conditions with planned second look [1].
The method inherits a range of problems, such as manage-
ment of the open abdomen, secondary closure of the fascia,
the development of ventral hernias, and enteroatmospheric
fistulas. Several different methods and strategies have been
argued to minimize the complications and lower nursing
requirements. ABThera KCI has been specially developed for
abdominal VAC [2].
One of the main outcomes of treatment with open abdo-
men is mortality, which has been reported to vary between
18 and 65% [3–7] dependent on patient selection. Another
important outcome is the secondary closure of the fascia
to prevent the development of symptomatic ventral hernias.
The rate of obtained secondary fascia closure varies between
48 and 100%, depending on patient selection and treatment
indication [2, 7–12]. Finally, the self-evaluated quality of life
is important, but seldom reported.
The aim of this study was, prospectively, to evaluate the
use of open abdomen with KCI ABThera VAC in a well-
defined geographically region (Region of Southern Den-
mark) with special focus on indications, course of treatment,
secondary fascia closure rate, fistula formation, incisional
hernia formation, self-assessed quality of life, and mortality.
2. Material and Methods
The study was designed as a prospective cohort study,
including all acute hospitals in Region of Southern Denmark
with a population of approximately 1.202 mill inhabitants.
The patients were included during the period from February
1 to December 31, 2013, at Odense University Hospital, and
from April 1 to December 31, 2013, at the district hospitals
(Svendborg, Esbjerg, and Aabenraa). During VAC treatment,
all patients received antibiotics according to department
instructions.
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Background data (age, sex, medical history, and BMI)
was obtained from the patient’s medical record. During
treatment, gastrointestinal function (stomach aspiration and
bowel movement) was assessed and fluid collected from the
VAC system was measured daily. At each dressing change, a
bacteria swap should be taken from the fascia edges and the
peritoneal cavity for culturing.The outline of the fascia defect
was drawn on a translucent sterile dressing placed over the
abdomen. Subsequently, the dressing was removed for later
calculation of the area of the abdominal wound. In addition,
a photo of the defect was taken for documentation before the
VAC system was applied. The area from the sterile dressing
was later transferred onto a cardboard with known paper
density, weighed using a precision paper weight (Jennings JZ
560 scale), and the area of the defect was calculated using the
following equation:
Paper area (cm2) =
paper mass (g)
paper density (g/cm2)
. (1)
It was registered whether a complete facial closure was
possible and on which postoperative day. The type of closure
was registered together with any complications experienced
during VAC treatment. Mortality during VAC treatment and
within 30 days was registered. The applied negative pressure
varied between 25 and 125mmHg, depending on surgeon
choice.
Successful treatment was defined as secondary suture of
the fascia after VAC treatment, with no need of mesh. Cases
where a second line of VAC treatment was needed were
classified unsuccessful together with incomplete secondary
closure of the fascia and the use of mesh in connection with
secondary closure.
Three months after termination of VAC treatment, all
surviving patients were invited to a follow-up. This included
a physical examination for any clinical detectable abdominal
wall defects, and the patients were asked to fill out a
questionnaire to assess their health-related quality of life (SF-
36v2).The answers were analyzed using the authorized scor-
ing software (QualityMetric Health Outcomes TM Scoring
Software). Data analysis was performed using the StataIC 12
program and were based on 𝑡-test (numerical data) and chi2-
tests (categorical data). A 𝑝 value < 0,05 was considered as
statistically significant.
3. Results
3.1. Indications for Open Abdomen. A total of 74 consecu-
tive patients were included in the study. The patients were
divided into 6 different groups according to the indications
for open abdomen treatment (Table 1). The most common
underlying pathology included 19 patients with intestinal
perforations, 12 with anastomotic dehiscence, 10 with ileus,
and 6 with ruptured abdominal aortic aneurysm. Abdominal
compartment syndrome (ACS) was defined as patients who
underwent laparotomy due to abdominal hypertension with
onset ofmanifestmultiorgan failure orwhere primary closure
was not possible. In these patients, the underlying pathol-
ogy was ruptured abdominal aortic aneurism (5), severe
intestinal edema following abdominal operation (5), ileus
(3), intestinal ischemia (3), and intraperitoneal hemorrhaging
(1). Indications for second look were intestinal ischemia,
damage control surgery, and inspection of an anastomosis.
If a patient had one or more sessions of VAC treatments
following an attempt of secondary closure, only the initial
was included. The group of others included one patient with
a large abdominal wall defect after necrosis of the fascia
and one patient with an infected ventral hernia mesh. The
last mentioned was the only patient, who developed an
enteroatmospheric fistula during VAC treatment. The fistula
was located on the ileum.
3.2. Procedure Related Data. A total of 70 patients (94,6%)
survived until termination of VAC treatment. Successful
treatment, defined as complete secondary closure of the
fascia without mesh immediately following VAC treatment,
was obtained in 84,3% (Table 2). Five patients required a
secondVAC treatment after the initial closure, and these were
included in the unsuccessful group.
3.3. Hernia and Quality of Life at Follow-Up. Three months
after treatment, 63 of the 74 patients were still alive. And of
these, 59 accepted to participate in a follow-up and completed
the SF-36 quality of life questionnaire. Clinical evaluation
revealed incisional hernia in 10 of the 59 patients (Table 3).
3.4. Microbial Results. Of the 74 patients included, results
for intra-abdominal bacteria growth analysis were obtained
in 63. Thirty-one had only one swap taken, and of these
20 showed bacterial growth. Thirty-two had multiple con-
secutive swaps taken in connection with dressing changes.
Of these, 20 were positive and stayed positive during the
treatment period, 4 were negative and stayed negative, 5 went
from initial positive to negative, and 3 went from initial
negative to positive. The most common bacteria cultured
were Enterococcus faecium, Enterococcus faecalis, and E. coli
(Table 4).
4. Discussion
Successful treatment, defined as achieving complete sec-
ondary closure of the fascia, without subsequent repeat of
the VAC treatment, was observed in 84,3% of the patients.
Risk factors for unsuccessful treatment were being female,
having preexisting ventral hernia, prolonged VAC treatment,
and large wound area. In trauma patients, secondary closure
was obtained in all, whereas ACS patients had the lowest
closure rate of 78,6%. At the three-month follow-up, 5
of the 59 patients had developed a symptomatic ventral
hernia, which indicated repair. In another 10 patients, a
minor ventral hernia had developed. It is not surprising
that the development of hernia was significantly higher in
the group of patients with an unsuccessful treatment, where
all demonstrated a ventral hernia at follow-up. In the two
patients with an infected mesh and necrosis of the fascia, the
goal of VAC treatment was not to obtain secondary closure
of the fascia. The rate of ventral hernia development was
comparable to those reported (2–20%) after laparotomy with
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Table 1: Patient background data and data regarding VAC treatments. Unless otherwise stated, the results are given as median (range) or
number𝑁 (%).
All Secondaryperitonitis
Abdominal
compartment
syndrome (ACS)
Fascia
dehiscence
Planned second
look Trauma Others
𝑁 74 29 17 11 10 5 2
Age (years) 64.4 (9–89) 63 (9–85) 71 (23–80) 69 (53–85) 63 (54–89) 28 (20–60) 61.5 (58–65)
Sex, men 47 (64%) 19 (65,52%) 12 (70,59%) 5 (45,45%) 6 (60%) 5 (100%) 0 (0%)
BMI 25.2(16.90–41.81)
24.94
(16.90–34.97)
24.01
(19.38–32.10)
25.6
(21.56–39.00)
25.94
(20.90–41.81)
27.62
(19.98–30.25)
24.3
(17.68–30.92)
Duration of
VAC (days) 4.5 (0–39) 4 (2–18) 5 (3–13) 6 (2–39) 2 (1–10) 6 (0–10) 3 (2–4)
VAC-changes 1 (0–16) 1 (0–7) 1 (0–6) 1 (0–16) 0 (0–3) 1 (0–4) 0,5 (0-1)
Intensive care
unit 52 (70%) 21 (72.41%) 14 (82.35%) 3 (27.27) 8 (80%) 5 (100%) 1 (50%)
Largest
laparotomy
area measured
(cm2)
143.5 (27–473) 203 (57–500) 140 (87–350) 116 (27–496) 121.5 (43–326) 263.5 (126–406) 173 (106–240)
Largest fluid
output per day
(ml)
1000 (0–11000) 1000 (0–3200) 1125 (500–11000) 900 (500–2300) 1000 (700–1900) 800 (500–4000) 500 (500-500)
Treatment
success 59 (84%) 23 (82.14%) 11 (78.57%) 10 (90.91%) 10 (100%) 5 (100%) 0 (0%)
Died prior to
closure 4 (5%) 1 (3.45%) 3 (17.65%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Died within 3
months 11 (15%) 3 (10.34%) 6 (35.29%) 1 (9.09%) 1 (10%) 0 (0%) 0 (0%)
t
Table 2: Clinical background data and procedure related data in thosewith an unsuccessful and successful treatment. Unless otherwise stated,
the results are given as median (range) or number𝑁 (%).
Treatment unsuccessful Treatment successful 𝑝 value
𝑁 (%) 11 (15.7%) 59 (84.3%)
Age (years) 64.3 (20–79) 61.5 (9–89) 0.62
Sex, men𝑁 4 (36.4%) 41 (69.5%) 0.035
BMI 25.4 (17.68–34.97) 26.2 (16.90–41.81) 0.68
Known ventral hernia prior to treatment 3 (27.3%) 4 (6.8%) 0.036
Duration of VAC (days) 10.8 (2–39) 5.2 (0–15) 0.0013
VAC-changes 4.2 (0–16) 1.6 (0–6) 0.0012
Wound area (cm2) 250 (57–496) 157.1 (27–500) 0.0059
Fluid output max (ml/day) 1224 (500–3100) 1190 (0–11000) 0.89
Died within 3 months 4 (36.4%) 3 (5.2%) 0.002
Table 3: Results from the three-month follow-up clinical examination and the quality of life questionnaire. The results are given as number
𝑁 (%). For the SF-36, the results given are mean value and confidence interval (95% CI).
Treatment successful Treatment unsuccessful 𝑝 value
Total 52 (88.1%) 7 (11.9%)
Ventral hernia 6 (11.5%) 4 (57.1%) 0.002
Large hernia needing repair/already repaired 2 (3.8%) 3 (42.6%) 0.002
SF-36 physical (95% CI) 41.75 (26–37) 31 (22–63) 0.0057
SF-36 mental (95% CI) 45.8 (21–69) 40.5 (21–70) 0.3193
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Table 4: The results of microbial culturing from peritoneal fluid
during VAC changes.
Microbe Number of patients
Enterococcus faecium 29
Enterococcus faecalis 11
Escherichia coli 10
Yeasts 6
Pseudomonas aeruginosa 5
Enterobacter cloacae 5
Proteus vulgaris 3
Staphylococcus haemolyticus 3
Klebsiella oxytoca 2
Klebsiella pneumoniae 2
Morganella morganii 2
Stenotrophomonas maltophilia 2
Aeromonas species 1
Citrobacter youngae 1
Serratia marcescens 1
Staphylococcus aureus 1
Bacillus cereus 1
primary fascia closure [13]. Unfortunately we were not able
to get information on the development of ventral hernia in
those who did not attend the follow-up. It is possible that
additional ventral hernias can present after the three months
of our follow-up.
The rate of secondary closure varies greatly in the liter-
ature, depending on indications for VAC, technique used,
and the underlying disease. Overall, the best results are
obtained in trauma patients undergoing damage control
surgery with secondary closure rates of up to 100% [8, 9, 11]
as obtained in our study. The use of VAC in the treatment
of diffuse peritonitis/abdominal sepsis has become more
common in recent years. The results are contradictory. In
some studies, VAC treatment significantly increases the rate
of fascia closure (73% versus 53%) and decreases mortality
compared to primary abdominal closure [14]. Others argue
that on demand relaparotomy is just as effective as open
abdomen with VAC [15]. Our closure rates in peritonitis
patients are similar to those previously reported [14, 15], but
our mortality of only 10% in these patients is lower than
the reported 30% mortality. Patient selection is an important
factor in this respect. Other important factors in obtaining
fascia closure are duration of VAC treatment and area of
the open wound. Also the technique for using VAC may be
important [16].
A dreaded complication of open abdomen is the for-
mation of enteroatmospheric fistulas, and the main causes
are iatrogenic serosal lacerations, mechanical irritation from
adhesive material, and adhesion splitting [17]. The incidence
of fistula formation has been reported to vary between 3 and
17% [2, 3]. One patient in our study (1,4%) developed a fistula
due to VAC treatment.This is low compared to the rate given
in the literature but shows that fistula formation is still a
complication to consider [17].
VAC treatment in animal models has been shown to
diminish the bacteria load, helping to clear infections [18].
However, the same effect has not been observed in clinical
conditions [19], where the development of superinfections
may be important [20]. In our study, only 5 patients of 25 with
initially positive bacteria growth cleared the intraperitoneal
bacteria during VAC treatment irrespective of the current
antibiotic treatment.Three patients with an initial sterile cul-
ture became infected. The presence of Enterococcus faecium,
Enterococcus faecalis, and E. coli indicates contamination
from the GI tract, whereas the presence of, for example,
Pseudomonas aeruginosa indicates nosocomial infection. A
tailored antibiotic treatment according to the results of
cultures from abdominal fluid might have a potential to
improve patient treatment. Further prospective studies are
needed to solve the problem.
Another important outcome is the self-evaluated quality
of life. Patients with unsuccessful treatment rated their phys-
ical health significantly lower than patients in the successful
group, which was to be expected. Besides being statistically
significant, the difference was also of clinical relevance.
Studies have shown that patients treated with open abdomen,
who could achieve closure of the fascia, had the same quality
of life as other patients undergoing similar surgery [5] or
as the general population [21], whereas patients with an
incisional hernia scored lower [7, 21, 22].The latter result was
confirmed in this study.However, these findings are subjected
to confounders, such as comorbidity and the presence of
stomas, which will affect the physical quality of life. The
relative low number of patients in the present study did
not allow sufficient statistical analysis on this problem. The
difference in physical health had no influence on the mental
health. This could be explained by the fact that the patient
despite their physical disabilities just was grateful for having
survived a serious and life-threatening disease or condition.
Mortality after three months was 15%, highest in the ACS
group. Complications to VAC treatment were not observed
in any of the mortality cases.
The multicenter design involving several different physi-
cians in different medical centers is a limitation in our
study, since proper technique using the open abdomen VAC
materials is essential to treatment success [16]. It appears
that the indication for open abdomen treatment is decisive
for outcome. However, the results from our study showed
that the abdominal VAC treatment, in the treatment of
patients with abdominal catastrophes, is safe with a relative
low complication rate. Whether it might be superior to
conventional treatment with primary closure when possible
has yet to be proven in a randomized study.
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